<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://industryfocusswitzerland.com/article/907003308-soma-to-develop-bedrocan-eu-gmp-cannabis-extracts-for-global-medical-markets</loc>
      <news:news>
        <news:publication>
          <news:name>Industry Focus Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T08:00:00+00:00</news:publication_date>
        <news:title>SOMAÍ to develop Bedrocan EU-GMP Cannabis Extracts for Global Medical Markets</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24024695-soma-white-background-3375x3375.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://industryfocusswitzerland.com/article/906975987-agrolidya-announces-strong-investor-demand-for-poultry-investment-project-in-turkey-as-phase-one-sells-out</loc>
      <news:news>
        <news:publication>
          <news:name>Industry Focus Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T17:34:54+00:00</news:publication_date>
        <news:title>AGROLIDYA Announces Strong Investor Demand for Poultry Investment Project in Turkey as Phase One Sells Out</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836504-poultry-farm-jpeg-1280x720.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://industryfocusswitzerland.com/article/907074659-addex-gabab-pam-candidate-demonstrates-robust-anti-tussive-activity-in-non-human-primate-chronic-cough-model</loc>
      <news:news>
        <news:publication>
          <news:name>Industry Focus Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T05:00:00+00:00</news:publication_date>
        <news:title>Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/e6c12443-4244-46f9-909c-5ab241bbea41/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://industryfocusswitzerland.com/article/906173515-the-medical-affairs-professional-society-maps-announces-presenters-for-their-2026-emea-annual-meeting-in-zurich</loc>
      <news:news>
        <news:publication>
          <news:name>Industry Focus Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T14:00:00+00:00</news:publication_date>
        <news:title>The Medical Affairs Professional Society (MAPS) Announces Presenters for their 2026 EMEA Annual Meeting in Zurich  </news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834739-new-zurich-logo-1000x346.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://industryfocusswitzerland.com/article/906922944-revmate-franchit-un-cap-strat-gique-et-valide-son-mod-le-avec-des-gains-mesurables-en-revenue-management-multi-h-tel</loc>
      <news:news>
        <news:publication>
          <news:name>Industry Focus Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T12:00:00+00:00</news:publication_date>
        <news:title>RevMate franchit un cap stratégique et valide son modèle avec des gains mesurables en revenue management multi-hôtel</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836140-revmate-lancement-2026-2659x2659.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://industryfocusswitzerland.com/article/906910831-updated-walmart-us-laboratory-assignment-list-expands-sgs-testing-scope</loc>
      <news:news>
        <news:publication>
          <news:name>Industry Focus Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T08:49:12+00:00</news:publication_date>
        <news:title>Updated Walmart US Laboratory Assignment List expands SGS testing scope</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836097-2885-walmart-4095x2732.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://industryfocusswitzerland.com/article/906937311-newcelx-updates-corporate-presentation-to-highlight-type-1-diabetes-flagship-program-following-strategic-collaboration-with-eledon-pharmaceuticals</loc>
      <news:news>
        <news:publication>
          <news:name>Industry Focus Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T11:37:00+00:00</news:publication_date>
        <news:title>NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ac801d4e-6ea5-4452-87c2-aa6a05bec73c/small/logo-positive-2x-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://industryfocusswitzerland.com/article/906909326-oculis-announces-completion-of-last-patient-visit-in-phase-3-diamond-program-with-ocs-01-eye-drops-for-the-treatment-of-diabetic-macular-edema</loc>
      <news:news>
        <news:publication>
          <news:name>Industry Focus Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T08:00:00+00:00</news:publication_date>
        <news:title>Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://industryfocusswitzerland.com/article/906786185-molecular-partners-presents-three-posters-at-aacr-2026-with-new-preclinical-data-for-first-switch-darpin-t-cell-engager-mp0632-and-dll3-radio-darpin</loc>
      <news:news>
        <news:publication>
          <news:name>Industry Focus Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-19T16:00:00+00:00</news:publication_date>
        <news:title>Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ac0d728a-e43a-4d2b-a9c5-52e74d0dd1eb/small/molecularpartners-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
</urlset>
